World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02434679
Date of registration: 30/04/2015
Prospective Registration: No
Primary sponsor: University Hospital, Limoges
Public title: Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns DAIR3N
Scientific title: Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns
Date of first enrolment: October 2014
Target sample size: 278
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02434679
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
France
Contacts
Name:     Antoine BEDU, MD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Limoges
Key inclusion & exclusion criteria

Inclusion Criteria:

- Mother-child pairs that will be included in the study will be the pairs of all the NB,
born in the center (in born) and hospitalized in the neonatology units of each center:

with a predictable stay = 3 weeks in the unit

Exclusion Criteria:

NB will not be included if:

- They exhibit a birth defect, especially on the digestive tract

- They are secondarily hospitalized after a postnatal transfer (out born).

- The parents express their objection for the child to take part in the study

- The stool sample of the mother has not been received



Age minimum: N/A
Age maximum: 1 Day
Gender: All
Health Condition(s) or Problem(s) studied
Bacteriology
Intervention(s)
Primary Outcome(s)
The occurrence over time of digestive acquisition of any type of RI [Time Frame: 3 weeks]
Secondary Outcome(s)
The occurrence over time of digestive acquisition of severals type of RI [Time Frame: 3 weeks]
Occurrence over time of digestive acquisition of MRB in NB hospitalized in neonatology units [Time Frame: 3 weeks]
Secondary ID(s)
I13024 DAIR3N
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history